Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis.
Ozaki T, Yumita S, Ogasawara S, Fujiya M, Tsuchiya T, Yoshino R, Sawada M, Akatsuka T, Izai R, Miwa C, Yonemoto T, Fujimoto K, Unozawa H, Fujiwara K, Kojima R, Kanzaki H, Koroki K, Inoue M, Kobayashi K, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Nakagawa R, Nakamoto S, Kato N. Ozaki T, et al. Among authors: miwa c. Hepatol Res. 2024 Jun 29. doi: 10.1111/hepr.14088. Online ahead of print. Hepatol Res. 2024. PMID: 38943555
Differences in Enantioselective Hydroxylation of 2,2',3,6-Tetrachlorobiphenyl (CB45) and 2,2',3,4',6-Pentachlorobiphenyl (CB91) by Human and Rat CYP2B Subfamilies.
Inui H, Ito T, Miwa C, Haga Y, Kubo M, Itoh T, Yamamoto K, Miyaoka M, Mori T, Tsuzuki H, Mise S, Goto E, Matsumura C, Nakano T. Inui H, et al. Among authors: miwa c. Environ Sci Technol. 2022 Jul 19;56(14):10204-10215. doi: 10.1021/acs.est.2c01155. Epub 2022 Jul 7. Environ Sci Technol. 2022. PMID: 35801261
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Redman MW, Papadimitrakopoulou VA, Minichiello K, Hirsch FR, Mack PC, Schwartz LH, Vokes E, Ramalingam S, Leighl N, Bradley J, Miao J, Moon J, Highleyman L, Miwa C, LeBlanc ML, Malik S, Miller VA, Sigal EV, Adam S, Wholley D, Sigman C, Smolich B, Blanke CD, Kelly K, Gandara DR, Herbst RS. Redman MW, et al. Among authors: miwa c. Lancet Oncol. 2020 Dec;21(12):1589-1601. doi: 10.1016/S1470-2045(20)30475-7. Epub 2020 Oct 27. Lancet Oncol. 2020. PMID: 33125909 Free PMC article. Clinical Trial.
Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis.
Kudo F, Watanabe Y, Iwai Y, Miwa C, Nagai Y, Ota H, Yabe H, Demitsu T, Hagiwara K, Koyama N, Koyama S. Kudo F, et al. Among authors: miwa c. Intern Med. 2018 Aug 1;57(15):2217-2221. doi: 10.2169/internalmedicine.9381-17. Epub 2018 Mar 9. Intern Med. 2018. PMID: 29526968 Free PMC article.
71 results